As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...

Zonsen PepLib Biotech Inc. ("PepLib") today announced that it has entered a global research and development (R&D) collaboration and license agreement with Eli Lilly and Company ("Lilly"). Under the ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

WASHINGTON, Jan. 21, 2026 /PRNewswire/ -- The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support early-stage biotechnology drug ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

Although a start-up's recent triumph is seen as a 'DeepSeek moment', domestic players still trail world-beating pharma firms, experts say When Zhao Hong, chief doctor of China's leading cancer ...

In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...